Basic Fibroblast Growth Factor (bFGF) related decapeptide 0.1% Solution, with Tacrolimus 0.1% ointment combination therapy compared with Tacrolimus 0.1% ointment monotherapy in the treatment of stable vitiligo: A Phase IV, randomized 12 months Study
Authors : Davinder Parsad, Kiran Godse, Bela Shah, Sudhakarrao Grandhi, Satyaprakash Mahajan, Sayantani Chakraborty, Sonal Shendkar, Akhilesh Sharma, Chirag Teli, Rahul Pathak, Supriya Ambedkar
DOI : 10.18231/j.ijced.2020.050
